Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $102.36 which represents a decrease of $-0.68 or -0.66% from the prior close of $103.04. The stock opened at $103.4 and touched a ...

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...

We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...

Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 2% over the past month. The stock hit a new 52-week high of $92.42 in the ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...

Boston Scientific (BSX) closed the most recent trading day at $91.99, moving +0.77% from the previous trading session. This change outpaced the S&P 500's 1.11% loss on the day. At the same time ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

Boston Scientific initially developed the concept for the Bolt IVL system which helped establish Bolt Medical in 2019. As a strategic investor in Bolt Medical, Boston Scientific has an equity ...